Bulletin
Investor Alert

ZIOPHARM Oncology Inc.

NAS: ZIOP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 13, 2019, 5:37 p.m.

/zigman2/quotes/200291745/composite

$

4.90

Change

-0.03 -0.61%

Volume

Volume 3,022

Quotes are delayed by 20 min

/zigman2/quotes/200291745/composite

Previous close

$ 5.07

$ 4.93

Change

-0.14 -2.76%

Day low

Day high

$4.90

$5.15

Open

52 week low

52 week high

$1.56

$7.25

Open

Insider Actions for ZIOPHARM Oncology Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/26/2019 Kevin G. Lafond
SVP, Treasurer & CAO
11,667   Disposition at $5.25 per share. 61,251
11/26/2019 Kevin G. Lafond
SVP, Treasurer & CAO
11,667   Derivative/Non-derivative trans. at $2.85 per share. 33,250
05/07/2019 James Anthony Cannon
Director
15,000   Derivative/Non-derivative trans. at $0.7 per share. 10,500
01/06/2019 Laurence James Neil Cooper
Chief Executive Officer; Director
165,178   Derivative/Non-derivative trans. at $2.24 per share. 369,998
01/06/2019 Laurence James Neil Cooper
Chief Executive Officer; Director
446,428   Award at $0 per share. 0
01/06/2019 Laurence James Neil Cooper
Chief Executive Officer; Director
337,266   Award at $0 per share. 0
01/06/2019 Kevin G. Lafond
SVP, Treasurer & CAO
37,122   Award at $0 per share. 0
01/06/2019 David M. Mauney
President
159,010   Award at $0 per share. 0
01/06/2019 Robert Hadfield
General Counsel and Secretary
117,572   Award at $0 per share. 0
12/31/2018 Laurence James Neil Cooper
Chief Executive Officer; Director
16,156   Derivative/Non-derivative trans. at $1.87 per share. 30,211
12/31/2018 Kevin G. Lafond
SVP, Treasurer & CAO
9,334   Derivative/Non-derivative trans. at $1.87 per share. 17,454
12/31/2018 Elan Z. Ezickson
Director
80,214   Award at $0 per share. 0
12/31/2018 Douglas W. Pagán
Director
40,107   Award at $0 per share. 0
12/30/2018 Laurence James Neil Cooper
Chief Executive Officer; Director
26,178   Derivative/Non-derivative trans. at $1.66 per share. 43,455
12/30/2018 Kevin G. Lafond
SVP, Treasurer & CAO
13,100   Derivative/Non-derivative trans. at $1.66 per share. 21,746
12/29/2018 Laurence James Neil Cooper
Chief Executive Officer; Director
42,920   Derivative/Non-derivative trans. at $1.66 per share. 71,247
12/29/2018 James Anthony Cannon
Director
4,315   Derivative/Non-derivative trans. at $1.66 per share. 7,162
12/29/2018 Kevin G. Lafond
SVP, Treasurer & CAO
17,667   Derivative/Non-derivative trans. at $1.66 per share. 29,327
05/05/2018 Laurence James Neil Cooper
Chief Executive Officer; Director
123,333   Derivative/Non-derivative trans. at $4.41 per share. 543,898
12/31/2017 Laurence James Neil Cooper
Chief Executive Officer; Director
16,157   Derivative/Non-derivative trans. at $4.14 per share. 66,889
12/31/2017 Kevin G. Lafond
SVP, Treasurer & CAO
9,333   Derivative/Non-derivative trans. at $4.14 per share. 38,638
12/31/2017 Caesar J. Belbel
COO, CLO, and Secretary
21,667   Derivative/Non-derivative trans. at $4.14 per share. 89,701
12/31/2017 Francois Lebel
Executive Vice President R&D
21,667   Derivative/Non-derivative trans. at $4.14 per share. 89,701
12/30/2017 Laurence James Neil Cooper
Chief Executive Officer; Director
26,178   Derivative/Non-derivative trans. at $4.14 per share. 108,376
12/30/2017 James Anthony Cannon
Director
4,301   Derivative/Non-derivative trans. at $4.14 per share. 17,806
12/30/2017 Kevin G. Lafond
SVP, Treasurer & CAO
13,100   Derivative/Non-derivative trans. at $4.14 per share. 54,234
12/30/2017 Michael Weiser
Director
6,021   Derivative/Non-derivative trans. at $4.14 per share. 24,926
12/30/2017 Caesar J. Belbel
COO, CLO, and Secretary
31,450   Derivative/Non-derivative trans. at $4.14 per share. 130,203
12/30/2017 Francois Lebel
Executive Vice President R&D
31,450   Derivative/Non-derivative trans. at $4.14 per share. 130,203
12/30/2017 Wyche Fowler
Director
6,882   Derivative/Non-derivative trans. at $4.14 per share. 28,491
12/30/2017 Murray F. Brennan
Director
6,813   Derivative/Non-derivative trans. at $4.14 per share. 28,205
12/29/2017 Laurence James Neil Cooper
Chief Executive Officer; Director
348,000   Award at $0 per share. 0
12/29/2017 James Anthony Cannon
Director
17,258   Award at $0 per share. 0
12/29/2017 Kevin G. Lafond
SVP, Treasurer & CAO
53,000   Award at $0 per share. 0
12/29/2017 Michael Weiser
Director
17,258   Award at $0 per share. 0
12/29/2017 Caesar J. Belbel
COO, CLO, and Secretary
87,000   Award at $0 per share. 0
12/29/2017 Francois Lebel
Executive Vice President R&D
116,000   Award at $0 per share. 0
12/29/2017 Wyche Fowler
Director
17,258   Award at $0 per share. 0
12/29/2017 Murray F. Brennan
Director
17,258   Award at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
1 Sales
11,667
11,667
Last 6 months
1 Purchases
1 Sales
11,667
11,667
Last 12 months
9 Purchases
9 Sales
1,244,386
306,515

Officers and Executives

Dr. Laurence James Neil Cooper
Chief Executive Officer & Director
Dr. David M. Mauney
President
Mr. Satyavrat Shukla
Chief Financial Officer & Executive Vice President
Ms. Lynn M. Ferrucci
SVP-IT, Human Resources & Administration
Dr. Eleanor M. de Groot
General Manager-Cell Therapy & Executive VP
Mr. Robert Hadfield
Secretary, Chief Compliance Officer & Executive VP
Dr. Chris Bowden
Director
Ms. Heidi M. Hagen
Director
Mr. Kevin G. Lafond
Treasurer, Chief Accounting Officer & SVP-Finance
Mr. Christopher Taylor
Vice President-Corporate Communications
Mr. Scott L. Tarriff
Independent Non-Executive Chairman
Mr. Elan Z. Ezickson
Independent Director
Mr. Douglas W. Pagán
Independent Director
Dr. Scott N. Braunstein
Independent Director
Link to MarketWatch's Slice.